top of page
  • Ramjawan, S., Gallow, S., Baker, M., Bihiha, C. et al. 2023. Watering the Seed-stories of personal Growth. Chapter 8: Woman in the Mirror. ISBN 978-0-6397-9624-6. Elevate Business solutions

  • Quarshie, G. Agu, L. Abogye, R. Gallow, S. Wilkinson, S. Mohamed, A and Gasper, T. 2022.

  • African Women Who Inspire. ISBN 9-798356-446054

  • Orlando, B. Gallow, S. 2021. Corporate Social Responsibility: Chapter one: Human Resources Remain Our Biggest Assets. ISBN 978-1-83880-939-3. Intech Open Limited UK.

  • Gallow, S., Nel, J. & Williams, A. 2020. A conceptual model to retain non-professionals in a private healthcare setting. SA Journal of Human Resource Management | Vol 18 | a1281 | DOI: https://doi.org/10.4102/sajhrm.v18i0.1281 |

  • Gallow, S. 2019. Retention Recipe: A Guide for Healthcare Professionals. ISBN 13: 978-3-639- 51411-7. http://www.scholars-press.com 

  • Gallow, S. 2019. HIV: An African Intervention Strategy. ISBN 13: 978-613-8-91525-6. http://www.scholars-press.com

  • Gallow, S. 2020. Breast cancer and cannabinoids. Open Access. https://www.researchgate.net/publication/335260048_Breast_Cancer_and_Cannabinoids_Evidence_based_confidence_level_and_Therapeutic_potential 

  • Reddy, S. 2015. UNISA. Development of a retention model for scarce skilled employees in the health sector. www.unisa.ac.za

  • Gallow, S. 2018. University of Roehampton UK. The effect of the Eastern Cape Department of Health’s HIV awareness campaigns at rural Mdtansane schools and villages. www.roehampton.ac.uk

  • Reddy, S. 2010. Investigation of high turnover in a private pathology lab in the Eastern Cape. UNISA library. www.unisa.ac.za

  • Reddy, S. 2009. Liver Cirrhosis. Medmall Article. www.medmall.co.za

  • Reddy, S. 2009. A Further Insight into Iron Deficiency Anemia. Medmall Article. ww.medmall.co.za

  • Reddy, S. 2009. Ethics in Medical Technology. Medmall. www.medmall.co.za

Publications 
  • 2023. Key note speaker at Hemp and Cannabis Conference in Bangkok Thailand

  • 2023. Panel discussion with Tswhane University of Technology. Prof Katerere, Dr Gallow, Dr Shavhani. Medical cannabinoids into products. Cannabis Expo KZN July 2023

  • 2023. World Data Congress India. The largest technological device on the planet remains a mystery. A deep dive into the brain and Neuroscience Techniques

  • 2023. North West University. Food security program: Cannabis and hemp as a food security

  • 2023. October. North West University. Aquaponics as a method of agriculture and food security

  • 2023. Cannabis Expo KZN. Key note speaker. Medical cannabis: A true life event.

  • 2022. Cannabis Europa. Medical Cannabis Research in South Africa

  • 2022. International Cannabis Conference (ICBC). Berlin Germany. Sponsored by EU to represent SA

  • 2022. Panel discussions on Global Governance and Africa. Nigeria

  • 2022. Presented at the Cannabis Expo Sandton. Key note speaker: Medical cannabis research in South Africa replacing opioids with medical cannabis for chronic pain

  • 2022. Panel discussion at the Cannabis Expo Sandton: Medical cannabis and women’s health

  • 2022. Woman’s day event. Plettenberg Bay Western Cape Panel discussion: Cannabis and women’s health

  • 2022. Womans day event: Key note speaker. Women in Medical cannabis

  • 2022. Dr Shiksha Gallow presents the medical segment every second week on Canna Sphere which is streamed on DSTB Cape TV Dubai. Hadarat Global woman’s summit, Business negotiations beyond borders. Participated in panel discussion: Using neuroscience to accelerate business

  • 2022. SCC International meeting: USA: Medical Cannabis in South Africa: The Future for a global healing awakening

  • 2022. Cannabis Expo Cape Town: Panel discussions: Cannabis and Covid-19. Science or Hype Presented at the Cannabis Expo Cape Town: Panel discussions: Medical cannabis- Learning from the global market 2022

  • 2022. Cape Town Cannbis Convention Panel discussions: Women in Cannabis: Change makers and leaders

  • 2021. Presented at South African Medical Association (SAMA): East London Life hospital: Medical cannabis and the evidence to treat patients

  • 2021. Cannabis Expo Cape Town: Key Note: Medical cannabis research and anecdotal evidence

  • 2021. Cannabis Convention (Sandton): Medical Cannabis research in South Africa. Key Note speaker

  • 2021. DRDAR and ECRDA government engagement. Medical cannabis and the Eastern Cape. October

  • 2021. Presented at International Cannabis Committee: Society of Cannabis Clinicians. Medical cannabis public health initiatives in South Africa. September

  • 2019. Presented at Toronto Canada for government conference: Medical cannabis in South Africa: Opportunities for the global market

  • 2019. Cannabis Conference in East London for government conference: Healing with cannabinoids: The Evidence

  • 2019. Gloabal CannaTech: Medical Cannabis: What’s the Evidence: Medical Cannabis Conference November

  • 2018. Presented at WESGRO: Medical cannabis: a Brief Push to the Past at Congress

  • 2018. Cape Town Cannabis Expo: Medical Cannabis: The Evidence

  • 2013. Leipzig Germany: Key Note speaker representing Wits health consortium: The H3Africa biorepository project lined to the HIV vaccine trial

  • 2013. Presented in Tanzania at the Medical Conference: Key Note speaker: The H3 Africa Biorepository global project started at Wits Health Consortium

  • 2011. Sun City Presented a paper on: “Laboratory Management: Back to the Future” at Path Tech Congress in Sun City

  • 2011. University of Pretoria Presented a paper on “Laboratory Automation in the Eastern Cape” at Biomeriux Congress in 2011

Presentations & Conferances
  • PHD research PI: Shiksha Gallow 2021-2024

    • To investigate the effect of cannabinoids on patients diagnosed with prostate cancer.

    • Role: Principal Investigator

  • LAB-ONQ-OPI-001 PI: Shiksha Gallow 2021-2023

    • To investigate the replacement of Opioids with Medical Cannabis for Pain Management within the South African population.

    • Role: Principal Investigator

  • POS 207/2023 PI: Shiksha Gallow 2023-2024

    • To investigate the effect of cannabinoids on patients diagnosed with prostate cancer.

    • Role: Research support investigator

  • CSIR Covid study PI: Alex Alexander 2023-2024

    • To design pcDNA3.1 plasmids encoding SARS-CoV-2 S proteins for different strains

    • To produce SARS-CoV-2 pseudotyped viruses

    • To determine the produced pseudotyped viruses’ infectivity

    • To investigate cannabinoids inhibitory activity against SARS-CoV-2 entry into cells.

    • Study of the cannabinoids’ cytotoxicity

    • .Role: Co Investigator

  • H3 Africa Biorepository PI: Ute Jentsch 2014-2017

    • To monitor the storage conditions of medical samples for cancer research. International study. Storage of samples in liquid nitrogen and other sources

    • Role: Co Principal Investigator

  • MTN 003 – USAID # IND#: 55,690 PI: Sinead Delany-Moretlwe 2009-2014

    • Phase 2B Safety and Effectiveness Study of Tenofovir 1% Gel, Tenofovir Disoproxil Fumarate Tablet and Emtricitabine/Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women

    • Role: Laboratory Operations and Management, CLS Chief Operations Officer.

  • FACTS – USAID # IND # 73, 382 PI: Helen Rees 2010 – 2015

    • A Phase III, Multi-Centre, Randomized Controlled Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel in the Prevention of Human Immunodeficiency Virus Type 1 Infection in Young Women, and to Examine Effects of the Microbicide on the Incidence of Herpes Simplex Virus Type 2 Infection.

    • Role: Laboratory Operations and Management, WHC CLS Chief Operations Officer

  • IAVI - USAID # GPO-A-00-06-00006-00 PI: Jill Gilmour 2005 – 2013

    • The International AIDS Vaccine Initiative (IAVI) is a non-profit public-private product development partnership founded in 1996 whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI's work focuses on four areas: accelerating scientific progress; mobilizing public support through issue advocacy and education; encouraging industrial involvement in AIDS vaccine development; and working to assure global access to a vaccine. IAVI is a global organization and employees are located in the US (New York head office and San Francisco office), Europe (Amsterdam office), Africa (Kenya office in Nairobi and South Africa office in Johannesburg) and India (New Delhi office).

    • Role: Laboratory Operations and Management, WHC CLS Chief Operations Officer

Ongoing Research Support
Publications, Research & Conferences
bottom of page